MCUJF logo

MCUJF Medicure Inc.

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$0.92
+0.07 (+8.24%)

Medicure Inc. operates as a biopharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the cardiovascular market, primarily serving Canada and the United States. Among its key offerings is AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist specifically designed to manage acute coronary syndrome, encompassing conditions like…

Market Cap: $9.60Mwww.medicure.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

83
83
Aug 14Aug 14

Quote

Day Range
$0.85 – $0.92
52-Week Range
$0.67 – $0.97
Volume
$7.7K
Market Cap
$9.60M
50-Day Avg
$0.77
200-Day Avg
$0.82
Prev Close
$0.85
Open
$0.92

Valuation & Ratios

P/E Ratio
-1.61
EPS
$-0.68
P/B Ratio
0.89
P/S Ratio
0.40
Debt/Equity
0.07
Current Ratio
1.02
Dividend Yield
+0.0%
Gross Margin
+39.0%

Returns & Efficiency

Return on Equity
-55.0%
Return on Assets
-28.4%
FCF Yield
-4.9%
EV/EBITDA
-2.01

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$28.83M$-7.09M$-0.68
2024$21.91M$-1.04M$-0.10
2023$21.69M$-922.0K$-0.09
2022$23.07M$1.36M$0.13
2021$21.74M$-727.0K$-0.07

Social Signal Score

33
5d
33
1 mentions
30d
33
1 mentions
60d
33
1 mentions
90d
33
1 mentions
news: 1

Earnings

Wed, Aug 19(in 3 days)

Consensus estimate $-0.05 per share

6of 7 quarters beat consensus

Typical surprise +8.4% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, May 21$-0.03 vs $-0.03beat
  • Wed, Nov 19$-0.09 vs $-0.09beat
  • Wed, Aug 20$-0.06 vs $-0.07beat
  • Wed, May 21$-0.05 vs $-0.06beat
  • Mon, Nov 25$0.05 vs $-0.05beat
  • Wed, Aug 14$-0.09 vs $-0.02miss

Estimates and results for MCUJF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

MCUJFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsaccessnewswire.com·22h ago·Negative

    …2026 and Schedules August 17, 2026 Conference Call WINNIPEG, MB / ACCESS Newswire / August 14, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended June 30, 2026 and will have a conference call to present the Financial Results on August 17, 2026 at …

    View source ↗